Toggle light / dark theme

Nicotinamide adenine dinucleotide replenishment rescues colon degeneration in aged mice

face_with_colon_three Year 2017 nad plus is essentially immortality of the colon which can reduce colon aging.


Boosting the level of a coenzyme regulating metabolism could help treat constipation and other aging-related intestinal problems. Researchers in Hangzhou, China, led by Qinsong Sheng from the First Affiliated Hospital of Zhejiang University and Zhenyu Ju from Hangzhou Normal University studied differences in colon function between young and old mice. They showed that older animals had more difficulty in defecation through the gastrointestinal tract and that this was associated with a lower level of the coenzyme nicotinamide adenine dinucleotide (NAD). Treatment with an NAD precursor improved defecation ability, whereas administering a drug that blocks NAD synthesis led to worsened colon function in mice. These findings point to NAD as a key regulator of colon motility and suggest a therapeutic strategy for older individuals with bowel-movement problems.

Anti-Aging Treatment Breakthrough: Japanese Scientists’ Regenerative Gene Transfer Success

face_with_colon_three year 2024.


Genes from regenerative organisms rejuvenate intestinal stem cells in fruit flies.

In a groundbreaking experiment, Japanese researchers transferred regenerative genes to fruit flies, leading to improved intestinal health and enhanced stem cell activity. This discovery opens new possibilities for anti-aging strategies in higher organisms, including humans, through targeted gene therapy.

Researchers including those from the University of Tokyo’s Graduate School of Pharmaceutical Sciences transferred genes from simple organisms capable of regenerating their bodies into common fruit flies, more complex animals that cannot. They found the transferred gene suppressed an age-related intestinal issue in the flies. Their results suggest studying genes specific to animals with high regenerative capability may uncover new mechanisms for rejuvenating stem cell function and extending the healthy lifespan of unrelated organisms.

Breakthrough Stem Cell Therapy Could Restore Vision for AMD Patients

A study suggests that patients with wet AMD may regain vision through a novel approach — removing abnormal blood vessels and transplanting stem cell-derived retinal cells.

Patients with complete vessel removal saw better outcomes, hinting at a potential game-changer for vision restoration.

The devastating impact of wet AMD.

Apertura Gene Therapy Supports the Broad Institute in Development of Gene Therapy for Prion Disease Using Engineered AAV Capsid Targeting TfR1 for CNS Delivery

Two remarkable innovations coming together to tackle prion disease: AAVs that leverage human receptors to cross the blood-brain-barrier + a way of epigenetically silencing the gene encoding prions. I recall reading those cited papers and both are amazing!


BOSTON and NEW YORK, Feb. 28, 2025 /PRNewswire/ — Apertura Gene Therapy, a biotechnology company focused on innovative gene therapy solutions, supports the Broad Institute of MIT and Harvard, and the Whitehead Institute in advancing a gene therapy approach for the treatment of prion disease. The project is led by the Vallabh-Minikel lab at the Broad Institute which is focused on finding a cure for prion disease, and their approach leverages two cutting-edge technologies developed at the Institutes of both the Broad and Whitehead: the CHARM platform designed in Dr. Jonathan Weismann’s lab, and TfR1 capsid, an engineered AAV designed in the lab of Dr. Ben Deverman, Director of Vector Engineering at the Broad Institute and scientific founder of Apertura.

Prion disease is a rare, fatal, neurodegenerative disorder caused by misfolded proteins. The new gene therapy aims to address the root cause by using CHARM (Coupled Histone tail for Autoinhibition Release of Methyltransferase) to target and silence the gene that codes for the disease-causing protein1. This payload will be combined with Apertura’s TfR1 capsid, an adeno-associated virus (AAV) capsid engineered to efficiently cross the blood-brain barrier by binding to the human TfR1 receptor, which facilitates iron transport into brain cells2. Together, these technologies represent a transformative approach to tackling CNS diseases.

“We are thrilled to see the progress being made in the development of this innovative therapy for prion disease,” said Dr. Sonia Vallabh, co-leader of the group at the Broad working on preventative therapies for prion disease. “The collaborative efforts between Apertura, the Broad Institute and the Whitehead mark a significant milestone toward addressing unmet needs in neurodegenerative disorders.”

Bile Duct Cancer Treatment

Bile duct cancer, also called cholangiocarcinoma, is a rare disease in which cancer cells form in the bile ducts. Learn more about this cancer and treatment options.


External and internal radiation therapy are used to treat bile duct cancer and may also be used as palliative therapy to relieve symptoms and improve quality of life.

Learn more about Radiation Therapy to Treat Cancer and Radiation Therapy Side Effects.

Anti-ageing jabs — they can rejuvenate mice, but will they work on humans?

“Of these children, 85% are going to beat their cancer, but it’s a win at a cost,” says Armstrong. “We know that these kids will have shortened lifespans. They often die young of chronic diseases like heart disease, stroke or secondary cancers which present much earlier. And we discovered about a decade ago that this is because they’re ageing much faster than their chronological age.”

In particular, this is reflected not just in their biology, but in physical frailty. When Kirsten Ness, a physical therapist and clinical epidemiologist at St Jude, assessed a group of childhood cancer survivors aged 24–41, she noted that when it came to heart function, flexibility, respiratory capacity and range of motion, they resembled people decades older. “We showed that at 30, they have physiological frailty that resembles people in their 70s and 80s, and it’s getting worse over time,” says Ness.

The underlying cause of this is senescence, a state in which cells cease to continue dividing as normal, but instead simply linger, refusing to die. Because of this quality, senescent cells have sometimes been described as “zombie cells” and they are now regarded as a driving force and a reflection of ageing. Over the course of a lifetime, our bodies incur increasing amounts of damage which in turn makes many of our cells, distributed throughout our body, more likely to become senescent.

Software Development Job Postings on Indeed in the United States

Frequency: Daily, 7-Day.

Indeed calculates the index change in seasonally-adjusted job postings since February 1, 2020, the pre-pandemic baseline. Indeed seasonally adjusts each series based on historical patterns in 2017, 2018, and 2019. Each series, including the national trend, occupational sectors, and sub-national geographies, is seasonally adjusted separately. Indeed switched to this new methodology in December 2022 and now reports all historical data using this new methodology. Historical numbers have been revised and may differ significantly from originally reported values. The new methodology applies a detrended seasonal adjustment factor to the index change in job postings. For more information, see Frequently Asked Questions regarding Indeed Data.

Copyrighted: Pre-approval required. Contact Indeed to request permission to use the data at their contact information provided here.